# Rodiola Ginseng (Rhodiola rosea)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/rodiola-ginseng
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-31
**Evidence Score:** 2 / 10
**Category:** Adaptogen
**Also Known As:** Rhodiola rosea, Arctic root, Golden root, Rose root, Roseroot, Aaron's rod, King's crown, Lignum rhodium, Orpin rose, Rhodiola, Russian rhodiola, Sedum rosea, Siberian ginseng root, Hong Jing Tian

## Overview

Rhodiola rosea is an adaptogenic herb whose primary bioactive compounds, rosavins and salidroside, modulate the [hypothalamic-pituitary-adrenal](/ingredients/condition/stress) (HPA) axis to buffer physiological and psychological stress responses. These compounds influence monoamine [neurotransmitter](/ingredients/condition/cognitive) systems and inhibit catechol-O-methyltransferase (COMT), prolonging the activity of dopamine and [serotonin](/ingredients/condition/mood) in the brain.

## Health Benefits

• Reduces depression symptoms - RCT with 89 patients showed significant improvements in overall depression, [insomnia](/ingredients/condition/sleep), and emotional instability after 6 weeks (moderate evidence quality)
• Alleviates stress-related fatigue - RCT with 60 adults demonstrated significant symptom reduction after 4 weeks of 576 mg/day (moderate evidence quality)
• Improves burnout symptoms - Open-label trial with 118 patients reported 87% improvement rate in stress resistance and quality of life measures (preliminary evidence quality)
• Enhances [physical performance](/ingredients/condition/energy) - Systematic review of 6 RCTs found moderate/good quality evidence for performance benefits
• Supports mental performance - Systematic review identified 4 RCTs with moderate/good quality evidence for [cognitive](/ingredients/condition/cognitive) benefits

## Mechanism of Action

Rhodiola rosea's key compounds, salidroside and rosavins, inhibit the enzyme catechol-O-methyltransferase (COMT), slowing the breakdown of catecholamine [neurotransmitter](/ingredients/condition/cognitive)s including dopamine, [serotonin](/ingredients/condition/mood), and norepinephrine in synaptic clefts. Salidroside also activates AMP-activated protein kinase (AMPK) and upregulates heat shock proteins (HSP70), enhancing cellular resilience to metabolic and [oxidative stress](/ingredients/condition/antioxidant). Additionally, Rhodiola modulates cortisol secretion by attenuating [HPA axis](/ingredients/condition/stress) hyperactivation, reducing stress-induced glucocorticoid release.

## Clinical Summary

A 6-week randomized controlled trial (RCT) in 89 patients with mild-to-moderate depression found that Rhodiola rosea extract SHR-5 produced significant improvements in overall depression severity, [insomnia](/ingredients/condition/sleep), and emotional instability compared to placebo, with evidence rated as moderate quality. A separate 4-week RCT involving 60 adults experiencing stress-related burnout demonstrated significant reductions in fatigue, exhaustion, and stress symptom scores following standardized Rhodiola supplementation. While these results are encouraging, most trials use relatively small sample sizes and short durations, limiting conclusions about long-term efficacy. Larger, multi-center RCTs with standardized extracts are needed to confirm these findings and establish optimal dosing protocols.

## Nutritional Profile

Rhodiola rosea is a bioactive-rich [adaptogen](/ingredients/condition/stress)ic root with negligible macronutrient content as used in supplemental doses (100–600 mg/day). Key bioactive compounds include: Rosavins (rosavin, rosarin, rosin) — primary marker compounds at approximately 3% by weight in standardized extracts (3:1 ratio rosavin:salidroside is the pharmaceutical standard); Salidroside (rhodioloside) — phenylpropanoid glycoside typically at 0.8–1% in standardized extracts, considered the primary [neuroprotective](/ingredients/condition/cognitive) and adaptogenic compound; Tyrosol — aglycone precursor to salidroside, present at trace levels (~0.05%); Flavonoids including rhodiolin, rodionin, rodiosin, acetylrodalgin, and tricin — present at ~1–2% total flavonoids; Phenolic acids including chlorogenic acid, hydroxycinnamic acid, and gallic acid derivatives; Monoterpenes and triterpenes including daucosterol and beta-sitosterol; Oxalic, citric, malic, and succinic organic acids. Micronutrients in the raw root include modest amounts of manganese (~0.3 mg/100g dry weight), iron, and zinc, though these are pharmacologically insignificant at supplement doses. Bioavailability: Salidroside demonstrates high oral bioavailability with rapid intestinal absorption; rosavins undergo partial hepatic first-pass [metabolism](/ingredients/condition/weight-management). Fat co-administration may modestly enhance absorption of lipophilic terpenoid fractions.

## Dosage & Preparation

Standardized extracts (3% rosavins, 1% salidroside): 340-680 mg/day for depression (6 weeks), 400 mg/day for burnout (12 weeks), 576 mg/day for fatigue (4 weeks). Higher doses up to 1360 mg/day have been proposed for major depressive disorder. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Rhodiola rosea is generally well tolerated at doses of 200–600 mg/day of standardized extract (3% rosavins, 1% salidroside), with mild side effects including dizziness, dry mouth, and vivid dreams reported in some users. Because it inhibits COMT and influences serotonin pathways, combining Rhodiola with monoamine oxidase inhibitors (MAOIs), selective [serotonin reuptake](/ingredients/condition/mood) inhibitors (SSRIs), or other antidepressants carries a theoretical risk of serotonin syndrome and should be done only under medical supervision. Rhodiola may also potentiate the effects of stimulants and interact with cytochrome P450 (CYP3A4) substrates by mildly modulating enzyme activity. Safety data for pregnant or breastfeeding women is insufficient, and use is not recommended in these populations without physician guidance.

## Scientific Research

A phase III RCT (PMID: 17990195) with 89 patients found SHR-5 extract at 340-680 mg/day significantly improved depression symptoms versus placebo. A systematic review (PMID: 21036578) of 11 RCTs found moderate to good quality evidence for benefits in [physical performance](/ingredients/condition/energy), mental performance, and [mental health](/ingredients/condition/mood) conditions. An open-label multicenter trial (PMC5370380) with 118 burnout patients showed marked improvements in stress resistance with 400 mg/day WS® 1375 extract.

## Historical & Cultural Context

Rhodiola rosea has a long history in traditional medicine systems of Russia, Scandinavia, and China as an [adaptogen](/ingredients/condition/stress) to treat stress-induced fatigue and depression. It has been used for centuries in these systems for enhancing physical and mental resilience against stress and improving [stamina](/ingredients/condition/energy).

## Synergistic Combinations

Ashwagandha, L-Theanine, Magnesium Glycinate, B-Complex Vitamins, Panax Ginseng

## Frequently Asked Questions

### How long does Rhodiola rosea take to work?

Clinical trials suggest meaningful effects on stress-related fatigue appear within 4 weeks of daily supplementation, while improvements in depression symptoms were observed after 6 weeks in a 89-patient RCT. Some users report acute stimulant-like alertness effects within hours of a single dose, likely due to rapid monoamine modulation, but these transient effects differ from sustained adaptogenic benefits that develop over weeks.

### What is the recommended dosage of Rhodiola rosea?

Most clinical trials have used standardized extracts containing 3% rosavins and 1% salidroside at doses ranging from 200 to 600 mg per day, typically taken in one or two divided doses before meals. The SHR-5 extract used in the depression RCT was administered at 340 mg/day, while fatigue studies have used up to 576 mg/day. Starting at a lower dose (200 mg/day) and titrating upward is advisable to assess individual tolerance.

### Can Rhodiola rosea be taken with antidepressants?

Combining Rhodiola rosea with antidepressants, particularly SSRIs or MAOIs, is not recommended without medical supervision due to its COMT-inhibiting activity and serotonergic influence, which creates a theoretical risk of serotonin syndrome. Additionally, Rhodiola may mildly inhibit CYP3A4 enzyme activity, potentially altering plasma concentrations of drugs metabolized by this pathway. Always consult a physician or pharmacist before combining Rhodiola with any prescription psychiatric medication.

### Is Rhodiola rosea the same as ginseng?

Rhodiola rosea and Panax ginseng are distinct plants from different botanical families — Rhodiola belongs to the Crassulaceae family, while Panax ginseng belongs to Araliaceae — though both are classified as adaptogens. Their active compounds differ significantly: Rhodiola's primary actives are rosavins and salidroside, whereas Panax ginseng's are ginsenosides. Their mechanisms overlap in HPA axis modulation but diverge at the molecular level, giving each a unique pharmacological profile.

### Does Rhodiola rosea help with anxiety?

Rhodiola rosea is not specifically approved or robustly studied for generalized anxiety disorder, but its modulatory effects on cortisol secretion and catecholamine neurotransmission may contribute to reduced anxiety symptoms in the context of stress-related conditions. The 6-week RCT in depressed patients noted improvements in emotional instability, a feature overlapping with anxiety, though anxiety was not the primary endpoint. Evidence for anxiety specifically remains preliminary and warrants dedicated controlled trials before firm conclusions can be drawn.

### What does clinical research show about Rhodiola rosea's effectiveness for depression and stress?

Multiple randomized controlled trials demonstrate that Rhodiola rosea has moderate evidence for reducing depression symptoms, with one study of 89 patients showing significant improvements in overall depression, insomnia, and emotional instability after 6 weeks. Research also supports its use for stress-related fatigue, with a 60-person RCT showing significant symptom reduction at 576 mg/day after 4 weeks. While the evidence quality is moderate rather than high, these findings suggest meaningful benefits for mood and stress recovery.

### Is Rhodiola rosea safe for long-term use?

Rhodiola rosea is generally considered safe for extended use, with most clinical trials examining it over periods of 4–6 weeks without serious adverse effects reported. However, long-term safety data beyond several months remains limited, so consulting with a healthcare provider about extended supplementation is advisable. Individuals with bipolar disorder or those taking certain psychiatric medications should exercise caution, as stimulant effects could potentially trigger manic episodes.

### Who benefits most from taking Rhodiola rosea supplements?

Rhodiola rosea appears most beneficial for individuals experiencing stress-related fatigue, burnout symptoms, or mild-to-moderate depression seeking natural support alongside conventional treatment. It may be particularly useful for those in high-stress occupations or those recovering from physical or emotional exhaustion. People with seasonal mood changes or those looking to improve resilience to chronic stress may also find it helpful, though it works best as part of a comprehensive wellness approach rather than as a standalone solution.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*